In the most recent instalment of IBTV’s Movers and Shakers of the week, Autolomous CEO & Co-Founder, Alexander Seyf, shared his experience of Phacilitate’s Advanced Therapies Week whilst highlighting the value of industry collaboration as we head into 2025.

Key takeaways include:
👉  Breaking down silos, building bridges:
Historically, the CGT landscape has been fragmented, with researchers, manufacturers, clinicians, and patients operating in relative isolation. Recently, the need for digitization has been recognized to bridge these gaps and empower stakeholders to collaborate more effectively.

👉 Enhanced connectivity:
Digital platforms foster closer connections between physicians, patients, and the broader industry. Physicians can track patient progress more effectively and industry players can leverage data-driven insights to optimize development strategies whilst simultaneously improving patient access and support.

👉 Ever-increasing excitement:
The overall sentiment surrounding CGT is shifting from cautious optimism to genuine excitement. We’re not just seeing progress on the scientific front; we’re also witnessing tangible improvements in cost and accessibility.